main-logo

ICD-10 Code C44.81 | Basal cell carcinoma of overlapping sites of skin Symptoms, Diagnosis, Billing

Basal cell carcinoma of overlapping sites of skin is a type of skin cancer that arises from the basal cells in the epidermis. It is characterized by uncontrolled growth of these cells, often due to prolonged exposure to ultraviolet (UV) radiation. This condition is clinically significant as it can lead to local tissue destruction and disfigurement if left untreated. The ICD-10 Code C44.81 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this prevalent skin cancer.

What is ICD-10 Code C44.81 for Basal cell carcinoma of overlapping sites of skin?

ICD-10 Code C44.81 represents basal cell carcinoma of overlapping sites of skin, indicating a malignant neoplasm originating from the basal layer of the epidermis. This code is used when the cancer affects multiple areas of the skin that overlap, complicating treatment and documentation. It is essential for accurate clinical documentation and billing, particularly in cases where the cancer's location and extent may influence treatment decisions and healthcare costs.

ICD-10 Code C44.81 – Clinical Definition and Explanation of Basal cell carcinoma of overlapping sites of skin

Basal cell carcinoma of overlapping sites of skin is primarily caused by cumulative sun exposure, leading to DNA damage in skin cells. It typically progresses slowly and may present as a non-healing sore, a shiny bump, or a scar-like area. Early detection and treatment are crucial to prevent local invasion and complications.

Key Clinical Features:

  • Commonly presents as a pearly or waxy bump on sun-exposed areas.
  • May appear as a flat, flesh-colored or brown scar-like lesion.
  • Slow-growing and rarely metastasizes, but can cause local tissue damage.
  • Higher incidence in fair-skinned individuals and those with a history of sunburn.

ICD-10 Code C44.81 for Basal cell carcinoma of overlapping sites of skin – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C44.81 is utilized to document the diagnosis of basal cell carcinoma affecting overlapping skin sites. It plays a vital role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.

What Does ICD-10 Code C44.81 for Basal cell carcinoma of overlapping sites of skin Mean in SOAP Notes?

ICD-10 Code C44.81 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of basal cell carcinoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C44.81 – Basal cell carcinoma of overlapping sites of skin

Basal cell carcinoma of overlapping sites of skin requires prompt medical intervention to prevent progression. Treatment options vary based on the size, location, and extent of the carcinoma.

Antibiotic Therapy:

  • Not applicable as basal cell carcinoma is not infectious.

Supportive Care:

  • Regular dermatological check-ups to monitor for new lesions.
  • Use of sunscreen to protect affected areas from UV exposure.
  • Education on skin self-examination for early detection of new lesions.

Infection Control:

  • Maintain proper wound care post-surgery to prevent infection.
  • Educate patients on signs of infection at the surgical site.

How to Document Symptoms of Basal cell carcinoma of overlapping sites of skin (ICD-10 C44.81) in SOAP Notes

Subjective:

  • Patient reports a non-healing sore on the face.
  • History of frequent sun exposure and sunburns.
  • Noticed a new growth that has been changing in appearance.
  • Denies pain but reports occasional itching in the area.

Objective:

  • Physical examination reveals a pearly, raised lesion on the right cheek.
  • Lesion measures approximately 1.5 cm in diameter.
  • No lymphadenopathy noted upon examination.
  • Skin biopsy performed to confirm diagnosis.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Basal cell carcinoma of overlapping sites of skin (ICD-10 Code C44.81)

Assessment:

  • Diagnosis: Basal cell carcinoma of overlapping sites of skin, moderate severity.
  • ICD-10 Code: C44.81.
  • Contributing factors: History of sun exposure and fair skin.

Plan:

  • Refer to dermatology for Mohs micrographic surgery.
  • Educate patient on sun protection measures.
  • Schedule follow-up in 3 months for monitoring.
  • Consider topical chemotherapy if surgery is not feasible.

Treatment & Plan Section for ICD-10 Code C44.81 – Basal cell carcinoma of overlapping sites of skin

  • Surgical excision is the first-line treatment for localized lesions.
  • Topical chemotherapy agents like imiquimod may be used for superficial lesions.
  • Cryotherapy can be considered for small, superficial basal cell carcinomas.
  • Regular follow-up appointments are essential for monitoring recurrence.

Using ICD-10 Code C44.81 for Basal cell carcinoma of overlapping sites of skin in Billing & SOAP Note Compliance

  • Ensure accurate documentation of lesion characteristics in Subjective (S) and Objective (O) sections.
  • Use C44.81 when multiple overlapping sites are affected.
  • Document treatment plans that align with clinical guidelines to support justified billing.
  • Include patient education and follow-up plans in the Plan (P) section.

ICD-10 Code C44.81 in Medical Billing and Insurance for Basal cell carcinoma of overlapping sites of skin

ICD-10 Code C44.81 is crucial for billing purposes in hospital, ER, or outpatient settings, ensuring accurate reimbursement for services rendered.

Billing Notes:

  • Document all relevant clinical findings and treatment plans to support the claim.
  • Use C44.81 in conjunction with procedure codes for surgical interventions.
  • Ensure that the diagnosis is clearly linked to the services provided in the medical record.

Common CPT Pairings:

CPT CodeDescription
11400Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm.
11100Biopsy of skin, excisional, including margins.
17000Destruction of skin lesions, up to 14 lesions.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C44.81 for Basal cell carcinoma of overlapping sites of skin

What are the common symptoms of basal cell carcinoma?

Common symptoms include a pearly or waxy bump, a flat scar-like lesion, or a sore that does not heal. Patients may also report itching or tenderness in the affected area.

How is basal cell carcinoma treated?

Treatment options include surgical excision, topical chemotherapy, cryotherapy, and Mohs micrographic surgery, depending on the size and location of the carcinoma.

Is basal cell carcinoma contagious?

No, basal cell carcinoma is not contagious. It is caused by genetic factors and environmental exposures, primarily UV radiation from the sun.

How often should patients with basal cell carcinoma have follow-up appointments?

Patients should have follow-up appointments every 6 to 12 months, depending on the extent of their disease and treatment history, to monitor for recurrence.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved